Pacific Edge says US medical and legal tides have turned in its favour

Pacific Edge says US medical and legal tides have turned in its favour
Pacific Edge chief executive Peter Meintjes. (Image: Pacific Edge)
Greg Hurrell
Pacific Edge is confident its newly announced $20 million capital raise, combined with new research results and professional validation, will keep it in the bladder cancer testing game.Chief executive Peter Meintjes says a clinical endorsement from the American Urological Association (AUA) should give it the medical and legal clout to regain Medicare coverage for its bladder cancer tests in the US.The dual NZX and ASX-listed medical technology company reported a net loss of $29.9m in the 12 months to March 31, 2025, compared with $29.5m in the...

More Markets

Seeking a faster, sharper ComCom
Economy

Seeking a faster, sharper ComCom

A ‘gold standard’ approach and siloed structure slow the Commerce Commission down.

NZ dollar on watch ahead of 3Q GDP, Fed signals
Markets

NZ dollar on watch ahead of 3Q GDP, Fed signals

Economists expect NZ GDP to shrink 0.3% in the June quarter after March growth.

Craigs beefs up in Hawkes Bay, eyes further expansion
Finance

Craigs beefs up in Hawkes Bay, eyes further expansion

Craigs looks to further expansion as it confirms the Somerset Smith Partners deal.

NZ sharemarket drifts flat as Fed decision looms
Markets Market Close

NZ sharemarket drifts flat as Fed decision looms

The S&P/NZX 50 Index closed down 0.05% or 6.5 points.

Tom Raynel 17 Sep 2025